Comcast (CMCSA) edged past profit forecasts in its latest quarter, driven by strong wireless subscriber growth and early signs that its push for simpler broadband pricing is resonating with customers. The media giant now sets its sights on converting promotional users and doubling down on network investments.
Medical device maker ResMed (RMD) reported fourth-quarter revenue of $1.42 billion, an 11% year-over-year increase that surpassed Wall Street forecasts. Non-GAAP earnings per share reached $2.81, also topping analyst expectations.
KeyBanc Capital Markets has upgraded LivaNova PLC (LIVN) from Sector Weight to Overweight, setting an $81 price target. The move reflects a broader positive shift in analyst sentiment towards the medical technology sector as valuation premiums ease.
A recent physician survey on renal denervation procedure volumes has prompted analysts to adopt a more measured view of Medtronic's near-term growth potential, even as the medical device giant remains a favored long-term holding.
A proposed near-zero payment increase for Medicare Advantage plans by the Trump administration has blindsided Wall Street, erasing billions in market value and raising fears of a prolonged downturn for major health insurers.
Medical Properties Trust (NYSE: MPW), a major healthcare real estate investment trust, is relocating its corporate headquarters to Birmingham, Alabama. The move is seen as a strategic effort to streamline operations and deepen ties with its primary U.S. hospital network, lenders, and investors, amid an evolving landscape for hospital ownership and healthcare infrastructure.
Rogers Communications Inc. reported robust fourth-quarter 2025 results, with revenue reaching C$6.17 billion and net income of C$743 million. The company's strategic pivot into sports and media, fueled by the MLSE acquisition and content partnerships, is emerging as a significant growth driver, challenging its traditional telecom narrative.
Rights groups document a disturbing pattern of Iranian security forces raiding hospitals to arrest injured protesters and the medical personnel treating them, transforming sanctuaries of care into sites of fear and reprisal.
CLEAR Secure, the biometric identity company known for its airport expedited lanes, is deepening its ties to core government systems. CEO Caryn Seidman Becker's appointment to the Federal Reserve Bank of New York's board and a new contract with the Centers for Medicare & Medicaid Services signal a strategic push into financial and public health infrastructure.
Chemed Corporation (NYSE: CHE) has seen its share price soften recently, reigniting investor debate over whether the healthcare services provider is now undervalued. With the stock trading around $430, a significant gap exists against some fair value estimates, even as operational challenges in its VITAS and Roto-Rooter segments loom.
Ahead of its February 26 earnings report, Medical Properties Trust (NYSE: MPW) is witnessing a notable spike in options activity, with call volume soaring to roughly five times its usual level. This surge in speculative interest comes as the healthcare REIT's shares hover around $5.05, showing recent momentum but still grappling with a challenging multi-year performance. Analysts are divided on whether the stock's current price reflects lingering past troubles or is beginning to price in a potential recovery narrative.
Medtronic secures a key European regulatory nod for its latest pulsed field ablation catheter while deepening its collaboration with Mindray, signaling a strategic push into high-growth areas of cardiac care and ambulatory surgery.
Iran has announced plans to designate the armed forces of European Union member states as terrorist organizations, a direct response to the EU's blacklisting of the Islamic Revolutionary Guard Corps. The escalation marks a new low in diplomatic relations and raises fears of further regional instability.
Goldman Sachs downgrades iHeartMedia to Sell, warning that shifting audio consumption and ad trends threaten growth, even as the company's TikTok partnership aims to capture younger audiences.
As Medical Properties Trust (MPW) prepares to report earnings, a spike in short-dated call options and a move to new Birmingham headquarters have investors weighing the REIT's path to profitability against persistent financial risks.
The Centers for Medicare & Medicaid Services (CMS) has unveiled a proposed payment update for Medicare Advantage plans that falls below industry expectations, coupled with stricter risk-adjustment regulations. This dual challenge pressures insurers like Oscar Health (NYSE: OSCR), whose tech-driven model is now under the microscope as profitability margins face a squeeze.
The Horatio Alger Award bestowed upon ResMed founder Dr. Peter Farrell underscores the company's decades-long leadership in sleep and respiratory care, bringing its financial performance and competitive strategy into sharper focus for investors.
Citizens reiterates a 'Market Outperform' rating and $396 price target for BeOne Medicines (ONC), driven by robust Phase 3 trial results in gastric cancer. The firm highlights the company's strong pipeline and cash position as key growth drivers.
ResMed reports robust revenue and margin expansion in its fiscal Q2 2026, driven by strong device and mask sales. Management highlights strategic investments in AI-powered patient tools and views GLP-1 medications as a potential catalyst for future demand.
ResMed Inc. reports an 11% revenue surge for its second fiscal quarter, driven by robust mask sales and strategic acquisitions, while navigating competitive pressures and capitalizing on emerging healthcare trends.
